Nasdaq:FBIO

Checkpoint Therapeutics Announces FDA Approval of UNLOXCYT(cosibelimab-ipdl)

WALTHAM, Mass., Dec. 13, 2024 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (Nasdaq: CKPT), today announced that the U.S. Food…

3 days ago

Checkpoint Therapeutics Announces FDA Approval of UNLOXCYT(cosibelimab-ipdl)

WALTHAM, Mass., Dec. 13, 2024 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (Nasdaq: CKPT), today announced that the U.S. Food…

4 days ago

Checkpoint Therapeutics Announces FDA Approval of UNLOXCYT(cosibelimab-ipdl)

WALTHAM, Mass., Dec. 13, 2024 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (Nasdaq: CKPT), today announced that the U.S. Food…

5 days ago